Ideaya Biosciences Stock Investor Sentiment
| IDYA Stock | USD 18.21 0.26 1.41% |
About 59% of Ideaya Biosciences' investor base is looking to short. The analysis of the overall investor sentiment regarding Ideaya Biosciences suggests that many traders are alarmed. The current market sentiment, together with Ideaya Biosciences' historical and current headlines, can help investors time the market. In addition, many technical investors use Ideaya Biosciences stock news signals to limit their universe of possible portfolio assets.
Comfort Level 41
Impartial
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Ideaya Biosciences' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Ideaya Biosciences.
News SentimentBullish | Hype SentimentBearish | Insider SentimentDisposing |
Ideaya Historical Sentiment
Although Ideaya Biosciences' investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Ideaya, such as negative comments on social media and news outlets, may cause fear in the market and push Ideaya Biosciences' investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Ideaya.
Ideaya |
Ideaya Biosciences Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Ideaya Biosciences can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Ideaya Biosciences Historical Investor Sentiment
Investor biases related to Ideaya Biosciences' public news can be used to forecast risks associated with an investment in Ideaya. The trend in average sentiment can be used to explain how an investor holding Ideaya can time the market purely based on public headlines and social activities around Ideaya Biosciences. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Ideaya Biosciences' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Ideaya Biosciences and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Ideaya Biosciences news discussions. The higher the estimate score, the more favorable the investor's outlook on Ideaya Biosciences.
Far too much social signal, news, headlines, and media speculation about Ideaya Biosciences that are available to investors today. That information is available publicly through Ideaya media outlets and privately through word of mouth or via Ideaya internal channels. However, regardless of the origin, that massive amount of Ideaya data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Ideaya Biosciences news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Ideaya Biosciences relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Ideaya Biosciences' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Ideaya Biosciences alpha.
Ideaya Biosciences Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | We Think IDEAYA Biosciences Can Afford To Drive Business Growth | 01/03/2025 |
2 | IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635 | 01/31/2025 |
3 | All You Need to Know About IDEAYA Biosciences Rating Upgrade to Buy | 02/10/2025 |
4 | Sage Therapeutics, Inc. Reports Q4 Loss, Lags Revenue Estimates | 02/11/2025 |
5 | IDEAYA Announces Further Gilead Sciences Clinical Study Collaboration Evaluating Combination of Trodelvy and IDE397 in MTAP-Deletion NSCLC | 02/13/2025 |
6 | Disposition of 12808 shares by Yujiro Hata of Ideaya Biosciences at 19.52 subject to Rule 16b-3 | 02/18/2025 |
7 | Acquisition by Yujiro Hata of 600000 shares of Ideaya Biosciences at 20.24 subject to Rule 16b-3 | 02/27/2025 |
8 | IDEAYA Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635 | 02/28/2025 |
9 | IDEAYA Biosciences Announces Collaboration with ATTMOS to Accelerate AIML-Enabled Drug Discovery for Unprecedented First-in-Class Oncology Targets | 03/03/2025 |
10 | Ideaya Biosciences stock hits 52-week low at 17.28 - Investing.com | 03/11/2025 |
Complementary Tools for Ideaya Stock analysis
When running Ideaya Biosciences' price analysis, check to measure Ideaya Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ideaya Biosciences is operating at the current time. Most of Ideaya Biosciences' value examination focuses on studying past and present price action to predict the probability of Ideaya Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ideaya Biosciences' price. Additionally, you may evaluate how the addition of Ideaya Biosciences to your portfolios can decrease your overall portfolio volatility.
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |